FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2514565087> ?p ?o ?g. }

• W2514565087 endingPage "e0162425" @default.
• W2514565087 startingPage "e0162425" @default.
• W2514565087 abstract "There is an unmet need to develop an innovative cardioprotective modality for acute myocardial infarction, for which interventional reperfusion therapy is hampered by ischemia-reperfusion (IR) injury. We recently reported that bioabsorbable poly(lactic acid/glycolic acid) (PLGA) nanoparticle-mediated treatment with pitavastatin (pitavastatin-NP) exerts a cardioprotective effect in a rat IR injury model by activating the PI3K-Akt pathway and inhibiting inflammation. To obtain preclinical proof-of-concept evidence, in this study, we examined the effect of pitavastatin-NP on myocardial IR injury in conscious and anesthetized pig models.Eighty-four Bama mini-pigs were surgically implanted with a pneumatic cuff occluder at the left circumflex coronary artery (LCx) and telemetry transmitters to continuously monitor electrocardiogram as well as to monitor arterial blood pressure and heart rate. The LCx was occluded for 60 minutes, followed by 24 hours of reperfusion under conscious conditions. Intravenous administration of pitavastatin-NP containing ≥ 8 mg/body of pitavastatin 5 minutes before reperfusion significantly reduced infarct size; by contrast, pitavastatin alone (8 mg/body) showed no therapeutic effects. Pitavastatin-NP produced anti-apoptotic effects on cultured cardiomyocytes in vitro. Cardiac magnetic resonance imaging performed 4 weeks after IR injury revealed that pitavastatin-NP reduced the extent of left ventricle remodeling. Importantly, pitavastatin-NP exerted no significant effects on blood pressure, heart rate, or serum biochemistry. Exploratory examinations in anesthetized pigs showed pharmacokinetic analysis and the effects of pitavastatin-NP on no-reflow phenomenon.NP-mediated delivery of pitavastatin to IR-injured myocardium exerts cardioprotective effects on IR injury without apparent adverse side effects in a preclinical conscious pig model. Thus, pitavastatin-NP represents a novel therapeutic modality for IR injury in acute myocardial infarction." @default.
• W2514565087 created "2016-09-16" @default.
• W2514565087 creator A5044498054 @default.
• W2514565087 creator A5048557340 @default.
• W2514565087 creator A5061398327 @default.
• W2514565087 creator A5062001972 @default.
• W2514565087 creator A5067878206 @default.
• W2514565087 creator A5070071025 @default.
• W2514565087 creator A5075158215 @default.
• W2514565087 date "2016-09-07" @default.
• W2514565087 modified "2023-10-16" @default.
• W2514565087 title "A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model" @default.
• W2514565087 cites W116717637 @default.
• W2514565087 cites W1485042465 @default.
• W2514565087 cites W1967228040 @default.
• W2514565087 cites W1983892946 @default.
• W2514565087 cites W1996753402 @default.
• W2514565087 cites W2003474213 @default.
• W2514565087 cites W2014285520 @default.
• W2514565087 cites W2019154778 @default.
• W2514565087 cites W2040200395 @default.
• W2514565087 cites W2043355876 @default.
• W2514565087 cites W2044718945 @default.
• W2514565087 cites W2061877572 @default.
• W2514565087 cites W2063704757 @default.
• W2514565087 cites W2069183328 @default.
• W2514565087 cites W2074041808 @default.
• W2514565087 cites W2078337754 @default.
• W2514565087 cites W2086200949 @default.
• W2514565087 cites W2107421104 @default.
• W2514565087 cites W2108790161 @default.
• W2514565087 cites W2110281714 @default.
• W2514565087 cites W2122713540 @default.
• W2514565087 cites W2136790664 @default.
• W2514565087 cites W2137625635 @default.
• W2514565087 cites W2137962262 @default.
• W2514565087 cites W2140600051 @default.
• W2514565087 cites W2149547404 @default.
• W2514565087 cites W2156389668 @default.
• W2514565087 cites W2170721979 @default.
• W2514565087 cites W2257033524 @default.
• W2514565087 cites W2331389349 @default.
• W2514565087 cites W2340015041 @default.
• W2514565087 cites W2460239821 @default.
• W2514565087 cites W2483878508 @default.
• W2514565087 cites W2547890628 @default.
• W2514565087 cites W4293084779 @default.
• W2514565087 doi "https://doi.org/10.1371/journal.pone.0162425" @default.
• W2514565087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5014419" @default.
• W2514565087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27603665" @default.
• W2514565087 hasPublicationYear "2016" @default.
• W2514565087 type Work @default.
• W2514565087 sameAs 2514565087 @default.
• W2514565087 citedByCount "37" @default.
• W2514565087 countsByYear W25145650872017 @default.
• W2514565087 countsByYear W25145650872018 @default.
• W2514565087 countsByYear W25145650872019 @default.
• W2514565087 countsByYear W25145650872020 @default.
• W2514565087 countsByYear W25145650872021 @default.
• W2514565087 countsByYear W25145650872022 @default.
• W2514565087 countsByYear W25145650872023 @default.
• W2514565087 crossrefType "journal-article" @default.
• W2514565087 hasAuthorship W2514565087A5044498054 @default.
• W2514565087 hasAuthorship W2514565087A5048557340 @default.
• W2514565087 hasAuthorship W2514565087A5061398327 @default.
• W2514565087 hasAuthorship W2514565087A5062001972 @default.
• W2514565087 hasAuthorship W2514565087A5067878206 @default.
• W2514565087 hasAuthorship W2514565087A5070071025 @default.
• W2514565087 hasAuthorship W2514565087A5075158215 @default.
• W2514565087 hasBestOaLocation W25145650871 @default.
• W2514565087 hasConcept C126322002 @default.
• W2514565087 hasConcept C164705383 @default.
• W2514565087 hasConcept C2776692505 @default.
• W2514565087 hasConcept C2776839432 @default.
• W2514565087 hasConcept C2779676291 @default.
• W2514565087 hasConcept C2780114680 @default.
• W2514565087 hasConcept C42219234 @default.
• W2514565087 hasConcept C500558357 @default.
• W2514565087 hasConcept C541997718 @default.
• W2514565087 hasConcept C71924100 @default.
• W2514565087 hasConcept C98274493 @default.
• W2514565087 hasConceptScore W2514565087C126322002 @default.
• W2514565087 hasConceptScore W2514565087C164705383 @default.
• W2514565087 hasConceptScore W2514565087C2776692505 @default.
• W2514565087 hasConceptScore W2514565087C2776839432 @default.
• W2514565087 hasConceptScore W2514565087C2779676291 @default.
• W2514565087 hasConceptScore W2514565087C2780114680 @default.
• W2514565087 hasConceptScore W2514565087C42219234 @default.
• W2514565087 hasConceptScore W2514565087C500558357 @default.
• W2514565087 hasConceptScore W2514565087C541997718 @default.
• W2514565087 hasConceptScore W2514565087C71924100 @default.
• W2514565087 hasConceptScore W2514565087C98274493 @default.
• W2514565087 hasIssue "9" @default.
• W2514565087 hasLocation W25145650871 @default.
• W2514565087 hasLocation W25145650872 @default.
• W2514565087 hasLocation W25145650873 @default.
• W2514565087 hasLocation W25145650874 @default.
• W2514565087 hasLocation W25145650875 @default.

• next